Keyue Liu Selected Research

Histamine H2 Receptors

3/2007	Histaminergic involvement in neuropathic pain produced by partial ligation of the sciatic nerve in rats.
3/2005	Prevention of brain infarction by postischemic administration of histidine in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keyue Liu Research Topics

Disease

15	Inflammation (Inflammations) 01/2022 - 12/2005
15	Ischemia 01/2016 - 12/2002
8	Neuralgia (Stump Neuralgia) 01/2022 - 03/2007
8	Pain (Aches) 01/2022 - 01/2016
8	Reperfusion Injury 02/2011 - 02/2004
7	Sepsis (Septicemia) 12/2021 - 07/2008
6	Brain Infarction 05/2011 - 03/2005
6	Infarction (Infarctions) 02/2011 - 06/2003
5	Hypersensitivity (Allergy) 01/2022 - 01/2013
5	Infections 12/2021 - 06/2015
5	Pneumonia (Pneumonitis) 01/2019 - 06/2015
5	Brain Injuries (Brain Injury) 10/2017 - 09/2006
5	Brain Edema (Cerebral Edema) 10/2017 - 09/2008
4	Brain Ischemia (Cerebral Ischemia) 01/2021 - 12/2005
4	Stroke (Strokes) 01/2021 - 01/2013
4	Hyperalgesia 01/2018 - 01/2016
3	Neuroinflammatory Diseases 01/2022 - 01/2016
3	Edema (Dropsy) 10/2018 - 09/2008
3	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2014 - 09/2012
2	Human Influenza (Influenza) 12/2021 - 01/2019
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2021 - 10/2018
2	Chronic Pain 04/2021 - 01/2013
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 05/2011
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2020 - 01/2017
2	Thromboinflammation 10/2018 - 07/2016
2	Pancreatitis 10/2018 - 12/2017
2	Peripheral Nervous System Diseases (PNS Diseases) 02/2016 - 01/2016
2	Diabetes Complications 09/2010 - 03/2010
2	Ischemic Stroke 01/2009 - 12/2007
2	Hepatic Encephalopathy 10/2007 - 04/2005
2	Acute Liver Failure (Fulminant Hepatic Failure) 10/2007 - 04/2005
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 04/2022
1	Cognitive Dysfunction 01/2022
1	Communicable Diseases (Infectious Diseases) 12/2021
1	Listeriosis (Listeria Infection) 12/2021
1	Shock 12/2021
1	Diabetic Angiopathies (Diabetic Angiopathy) 11/2021
1	Trigeminal Nerve Diseases (Trigeminal Nerve Disorders) 04/2021
1	Trigeminal Nerve Injuries 04/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2021
1	Ulcer 01/2021
1	Burns 01/2021
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020

Drug/Important Bio-Agent (IBA)

38	HMGB1 Protein (HMG1)IBA 04/2022 - 12/2007
11	Monoclonal AntibodiesIBA 04/2021 - 12/2007
11	Histamine (Histamine Dihydrochloride)FDA Link 08/2015 - 01/2004
7	histidine-rich proteinsIBA 04/2022 - 11/2009
7	Histidine (L-Histidine)FDA Link 02/2011 - 02/2004
5	Advanced Glycation End ProductsIBA 11/2021 - 03/2010
5	Therapeutic UsesIBA 06/2020 - 01/2009
4	Toll-Like Receptor 4IBA 01/2019 - 01/2016
3	Minocycline (Cyclops)FDA LinkGeneric 01/2022 - 12/2017
3	LipopolysaccharidesIBA 12/2021 - 04/2016
3	glycolaldehydeIBA 11/2021 - 09/2009
3	Nuclear Proteins (Protein, Nuclear)IBA 10/2021 - 01/2016
3	Glutamic Acid (Glutamate)FDA Link 01/2021 - 01/2004
3	CytokinesIBA 09/2020 - 02/2011
3	Neutralizing AntibodiesIBA 01/2019 - 02/2011
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2011
3	Receptor for Advanced Glycation End ProductsIBA 12/2017 - 01/2016
3	GlyceraldehydeIBA 08/2017 - 09/2009
3	thioperamideIBA 09/2008 - 12/2005
3	Dopamine (Intropin)FDA LinkGeneric 10/2007 - 01/2004
2	Clodronic Acid (Clodronate)IBA 01/2022 - 12/2017
2	Glycyrrhizic Acid (Glycyrrhizin)IBA 01/2022 - 10/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 09/2020
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 01/2019
2	GlucocorticoidsIBA 01/2020 - 12/2002
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2018 - 01/2016
2	ThrombomodulinIBA 12/2017 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2017 - 11/2009
2	salicylhydroxamic acid (SHAM)IBA 01/2016 - 03/2007
2	Histamine H2 ReceptorsIBA 03/2007 - 03/2005
2	metoprineIBA 03/2007 - 12/2005
2	Histamine H3 Receptors (Histamine H3 Receptor)IBA 03/2007 - 02/2007
1	CalciumIBA 01/2022
1	Liposomes (Liposome)IBA 01/2022
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2022
1	AcidsIBA 01/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	Histones (Histone)IBA 10/2021
1	AlarminsIBA 04/2021
1	AcetoneIBA 04/2021
1	mirogabalinIBA 04/2021
1	Macrophage Colony-Stimulating FactorIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2021
1	N-Methylaspartate (NMDA)IBA 01/2021
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2021
1	CateninsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020

Therapy/Procedure

10	Ligation 01/2022 - 03/2007
10	Therapeutics 12/2021 - 05/2011
4	Injections 01/2022 - 02/2007
3	Intravenous Injections 01/2013 - 12/2007
2	Intraperitoneal Injections 01/2021 - 10/2018
1	Regenerative Endodontics 01/2021